 | |
| Clinical data | |
|---|---|
| Other names | Testosterone 17β-trimethylsilyl ether; TestosteroneO-trimethylsilyl ether; 17β-Trimethylsilyltestosterone;O-Trimethylsilyltestosterone; 17β-(trimethylsiloxy)androst-4-en-3-one; SC-16148; NSC-95147 |
| Routes of administration | By mouth,intramuscular injection,subcutaneous injection |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.023.414 |
| Chemical and physical data | |
| Formula | C22H36O2Si |
| Molar mass | 360.613 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Silandrone (INNTooltip International Nonproprietary Name,USANTooltip United States Adopted Name) (developmental code nameSC-16148), also known astestosterone 17β-trimethylsilyl ether or17β-trimethylsilyltestosterone, as well as17β-(trimethylsiloxy)androst-4-en-3-one, is asyntheticanabolic-androgenic steroid (AAS) and anandrogen ether – specifically, the 17β-trimethylsilylether oftestosterone – which was developed by theG. D. Searle & Company in the 1960s but was never marketed.[1] It has a very longduration of action when given viasubcutaneous orintramuscular injection, as well as significantly greaterpotency than that oftestosterone propionate.[2][3] In addition, silandrone, unliketestosterone and mostesters of testosterone like testosterone propionate, isorally active.[4]
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
